BT3.F - BioTime, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.9320
+0.0060 (+0.65%)
At close: 8:00AM CEST
Stock chart is not supported by your current browser
Previous Close0.9260
Open0.9320
Bid0.9400 x 250000
Ask0.9780 x 250000
Day's Range0.9320 - 0.9320
52 Week Range0.7520 - 2.4800
Volume400
Avg. Volume1,669
Market Cap141.584M
Beta (3Y Monthly)2.62
PE Ratio (TTM)2.10
EPS (TTM)0.4430
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • BioTime (BTX) Q1 2019 Earnings Call Transcript
    Motley Fool12 days ago

    BioTime (BTX) Q1 2019 Earnings Call Transcript

    BTX earnings call for the period ending March 31, 2019.

  • Associated Press17 days ago

    BioTime: 1Q Earnings Snapshot

    On a per-share basis, the Alameda, California-based company said it had profit of 30 cents. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • Associated Press2 months ago

    BioTime: 4Q Earnings Snapshot

    The Alameda, California-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share. The results met Wall Street expectations. The average ...

  • Associated Press7 months ago

    BioTime: 3Q Earnings Snapshot

    On a per-share basis, the Alameda, California-based company said it had net income of 53 cents. Losses, adjusted for non-recurring gains, were 7 cents per share. The biotechnology company posted revenue ...

  • Earnings Preview: BioTime (BTX) Q3 Earnings Expected to Decline
    Zacks7 months ago

    Earnings Preview: BioTime (BTX) Q3 Earnings Expected to Decline

    BioTime (BTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Can The Uptrend Continue for BioTime (BTX)?
    Zacks9 months ago

    Can The Uptrend Continue for BioTime (BTX)?

    Investors certainly have to be happy with BioTime, Inc. (BTX) and its short term performance.

  • BioTime (BTX) Reports Q2 Loss, Tops Revenue Estimates
    Zacks10 months ago

    BioTime (BTX) Reports Q2 Loss, Tops Revenue Estimates

    BioTime (BTX) delivered earnings and revenue surprises of 33.33% and 671.82%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press10 months ago

    BioTime: 2Q Earnings Snapshot

    The Alameda, California-based company said it had a loss of 3 cents per share. Losses, adjusted for non-recurring gains, were 6 cents per share. The biotechnology company posted revenue of $2.5 million ...

  • Here's Why BioTime, Inc Rose as Much as 14.3% Today
    Motley Fool10 months ago

    Here's Why BioTime, Inc Rose as Much as 14.3% Today

    The small-cap biopharma company issued a simple reminder to investors.

  • BioTime (BTX) in Focus: Stock Moves 7.3% Higher
    Zacks10 months ago

    BioTime (BTX) in Focus: Stock Moves 7.3% Higher

    BioTime (BTX) was a big mover last session, as the company saw its shares rise more than 7% on the day.